Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07352592 · ClinicalTrials.gov registry record · NA
Process-Based Approach Case Series For Anxiety Problems
A NA study, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT07352592: Recruiting NA study, sponsored by University of Alabama at Birmingham.
NCT07352592 is a NA study that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07352592, a NA study, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
A case series of PBA intervention for anxiety problems.
Primary Outcome
Anxiety scale
Interventions
- BEHAVIORAL Process-Based Approach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
What NCT07352592 shows while recruiting
NCT07352592 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Process-Based Approach is the first listed.
NCT07352592 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07352592 about?
NCT07352592 is a clinical study titled "Process-Based Approach Case Series For Anxiety Problems". A case series of PBA intervention for anxiety problems.
What is the current status of trial NCT07352592?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-06-01. Estimated completion is 2030-12-31.
What interventions are being tested in trial NCT07352592?
The interventions under investigation include: Process-Based Approach (BEHAVIORAL).
Who is sponsoring clinical trial NCT07352592?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07352592's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI